rapilysin
actavis group ptc ehf - reteplase - hjerteinfarkt - antithrombotic agents - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
banminth vet 2.2 % w/w
zoetis animal health aps - pyrantelembonat - oralpasta - 2.2 % w/w
bisoprolol sandoz 1.25 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 1.25 mg
bisoprolol sandoz 2.5 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 2.5 mg
bisoprolol sandoz 5 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 5 mg
bisoprolol sandoz 7.5 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 7.5 mg
bisoprolol sandoz 10 mg
sandoz a/s - bisoprololfumarat - tablett, filmdrasjert - 10 mg
isoptin retard 240 mg
viatris as - verapamilhydroklorid - depottablett - 240 mg
isoptin retard 120 mg
viatris as - verapamilhydroklorid - depottablett - 120 mg
lariam 250 mg
cheplapharm arzneimittel gmbh - meflokinhydroklorid - tablett - 250 mg